Proponents of price controls are wagering that savings on medicines will outweigh the lost benefits. The opposite is true.

Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and ...

Scientists at Scripps Research and its drug discovery arm, Calibr-Skaggs, develop first-in-class small molecules to repair damaged tissues of the heart, lungs, joints, and more LA JOLLA, ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Jacob Petersen, DMSc, Novo Nordisk senior vice president, head of global nucleic acid therapies [GEN/Alex Philippidis] LEXINGTON, MA—For Jacob Petersen, DMSc, Novo Nordisk’s quest to treat diabetes ...

COPENHAGEN--(BUSINESS WIRE)--Orbis Medicines, a leader in oral macrocycle drug discovery, today announced a research collaboration and option to an exclusive license with Vivtex, a biotech company ...

Kirsten Axelsen recently testified before the Senate Finance Committee’s hearing Lower Health Care Costs for Americans: Understanding the Benefits of the Inflation Reduction Act. Chairman Wyden, ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Drug discovery remains unevenly distributed worldwide. While many countries in the Global South carry a high burden of infectious, neglected, inflammatory, ...

Medicare drug price negotiation could have significant impacts on investment in post-approval studies for cancer treatment including for new disease indications, small patient populations with high ...